Rothman James

Director at BRIGHTPOINT INC · on record since Oct 3, 2023
Former Director at BRIGHTPOINT INC · on record since Oct 3, 2023
Sr. Mng. Dir., Strct. Credit at ACA Capital Holdings Inc · on record since Nov 17, 2006
See Remarks at ACA Capital Holdings Inc · on record since Aug 2, 2007
Director at Adhera Therapeutics, Inc. · on record since Jun 12, 2008
Director at INTROGEN THERAPEUTICS INC · on record since Aug 13, 2008
Director at Bruker Cellular Analysis, Inc. · on record since Jul 16, 2020

Insider trading activity of Rothman James

Transactions on record: 32; since Nov 17, 2006

Open-market buys: 4; $103.7K

Open-market sells: 8; $13M

Companies traded: 5; last filing Oct 3, 2023

Figures computed from official regulatory filings — .

Companies where Rothman James has traded

BRIGHTPOINT INC1 tx · Oct 3, 2023
Bruker Cellular Analysis, Inc.17 tx · $14.1M · Aug 1, 2022
Adhera Therapeutics, Inc.5 tx · $809.2K · May 21, 2009
INTROGEN THERAPEUTICS INC2 tx · Aug 13, 2008
ACA Capital Holdings Inc7 tx · $6.3K · Aug 2, 2007

Track record of Rothman James

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Rothman James

Co-insiders of Rothman James

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BRIGHTPOINT INCListing unverified	Oct 3, 2023	Other	-118,810	—	n/a (No price was disclosed in the filing)		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Aug 1, 2022	AwardD (derivative)	32,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Aug 1, 2022	Award	19,565	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Nov 10, 2021	Buy	4,000	24.35 USD	$97.4K	conv 59Unusual sizeFirst in 12mo	SEC
Bruker Cellular Analysis, Inc.Listing unverified	May 18, 2021	Award	1,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	May 18, 2021	AwardD (derivative)	4,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 9, 2021	Sell	-140,000	52.75 USD	$7.4M	Unusual size	SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-11,152	53.23 USD	$593.6K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-6,044	60.03 USD	$362.8K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-13,711	60.81 USD	$833.8K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Exercise	250,000	2.54 USD	$635K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-52,245	60.06 USD	$3.1M		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	ExerciseD (derivative)	-125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Exercise	125,000	2.50 USD	$312.5K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-2,254	54.20 USD	$122.2K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-8,848	53.85 USD	$476.5K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	ExerciseD (derivative)	-250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-1,901	57.26 USD	$108.9K		SEC
Adhera Therapeutics, Inc.Listing on record	May 21, 2009	AwardD (derivative)	46,000	1.52	$69.9K		SEC
INTROGEN THERAPEUTICS INCListing unverified	Aug 13, 2008	AwardD (derivative)	145,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INTROGEN THERAPEUTICS INCListing unverified	Aug 13, 2008	AwardD (derivative)	33,600	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	104,370	2.19	$228.6K		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	104,370	3.19	$332.9K		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	45,000	1.19	$53.6K		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	104,371	1.19	$124.2K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BRIGHTPOINT INCListing unverified	Oct 3, 2023	Other	-118,810	—	n/a (No price was disclosed in the filing)		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Aug 1, 2022	AwardD (derivative)	32,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Aug 1, 2022	Award	19,565	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Nov 10, 2021	Buy	4,000	24.35 USD	$97.4K	conv 59Unusual sizeFirst in 12mo	SEC
Bruker Cellular Analysis, Inc.Listing unverified	May 18, 2021	Award	1,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	May 18, 2021	AwardD (derivative)	4,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 9, 2021	Sell	-140,000	52.75 USD	$7.4M	Unusual size	SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-11,152	53.23 USD	$593.6K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-6,044	60.03 USD	$362.8K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-13,711	60.81 USD	$833.8K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Exercise	250,000	2.54 USD	$635K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-52,245	60.06 USD	$3.1M		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	ExerciseD (derivative)	-125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Exercise	125,000	2.50 USD	$312.5K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-2,254	54.20 USD	$122.2K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-8,848	53.85 USD	$476.5K		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	ExerciseD (derivative)	-250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Bruker Cellular Analysis, Inc.Listing unverified	Mar 5, 2021	Sell	-1,901	57.26 USD	$108.9K		SEC
Adhera Therapeutics, Inc.Listing on record	May 21, 2009	AwardD (derivative)	46,000	1.52	$69.9K		SEC
INTROGEN THERAPEUTICS INCListing unverified	Aug 13, 2008	AwardD (derivative)	145,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INTROGEN THERAPEUTICS INCListing unverified	Aug 13, 2008	AwardD (derivative)	33,600	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	104,370	2.19	$228.6K		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	104,370	3.19	$332.9K		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	45,000	1.19	$53.6K		SEC
Adhera Therapeutics, Inc.Listing on record	Jun 12, 2008	AwardD (derivative)	104,371	1.19	$124.2K		SEC